CN Patent

CN112939967B — 吡唑并[1,5-a]吡啶类化合物及其制备方法和应用

Assigned to Shenzhen Zhongge Biological Technology Co Ltd · Expires 2024-08-27 · 2y expired

What this patent protects

本发明涉及一种吡唑并[1,5‑a]吡啶类化合物及其制备方法和应用，包括所述化合物作为活性成分的药物组合物或其药学上可接受的盐。本发明进一步涉及式(I)化合物在用于治疗和预防可用RET激酶抑制剂治疗的疾病，包括由RET激酶介导的疾病或病症。

USPTO Abstract

本发明涉及一种吡唑并[1,5‑a]吡啶类化合物及其制备方法和应用，包括所述化合物作为活性成分的药物组合物或其药学上可接受的盐。本发明进一步涉及式(I)化合物在用于治疗和预防可用RET激酶抑制剂治疗的疾病，包括由RET激酶介导的疾病或病症。

Drugs covered by this patent

Patent Metadata

Patent number
CN112939967B
Jurisdiction
CN
Classification
—
Expires
2024-08-27
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Zhongge Biological Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.